Catalyst Biosciences, Inc.
-
Ticker
CBIO
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in South San Francisco, California
Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hematologic and complement-mediated disorders. Their protease engineering platform includes two late-stage clinical programs in hemophilia; a research program on engineering of subcutaneous (SQ) complement inhibitors; and a partnered preclinical development program with Biogen
…More for dry age-related macular degeneration (AMD). The product candidates generated by their protease engineering platform have improved functionality and potency that allow for: SQ administration of recombinant coagulation factors and complement inhibitors; low-dose, high activity gene therapy constructs; and less frequently dosed intravitreal therapeutics.
REPORT RATINGS
4.8 / 5.0 (156)
Catalyst Biosciences, Inc. reports have an aggregate usefulness score of 4.8 based on 156 reviews.
Catalyst Biosciences, Inc.
Most Recent Annual Report
MOST RECENT
2022 Annual Report and Form 10K
Older/Archived Annual Reports